Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Tewari

Showing results (61-70 of 349) with videos related to

Pageof 35
Sort By:
Recent Patents on Biotechnology|March 11, 2016
Recent Patents for Homologous Recombination Deficiency Assays Among Women with Ovarian CancerChristopher J LaFargue, Krishnansu S Tewari
Gynecologic Oncology|October 15, 2020
The current landscape of molecular profiling in the treatment of epithelial ovarian cancerCarolyn E Haunschild, Krishnansu S Tewari
Expert Review of Anticancer Therapy|October 18, 2016
The safety and efficacy of bevacizumab in the treatment of patients with recurrent or metastatic cervical cancerLindsey E Minion, Krishnansu S Tewari
Clinical Advances in Hematology & Oncology : H&O|February 4, 2022
Current and emerging immunotherapies for recurrent cervical cancerMarisa C Liu, Krishnansu S Tewari
Expert Review of Clinical Pharmacology|July 3, 2014
PARP inhibition and synthetic lethality in ovarian cancerRamez N Eskander, Krishnansu S Tewari
Expert Opinion on Pharmacotherapy|February 4, 2015
Integration of bevacizumab with chemotherapy doublets for advanced cervical cancerLauren S Krill, Krishnansu S Tewari
Clinical Advances in Hematology & Oncology : H&O|February 13, 2015
Development of a platform for systemic antiangiogenesis therapy for advanced cervical cancerKrishnansu S Tewari, Bradley J Monk
Current Opinion in Obstetrics & Gynecology|January 3, 2023
Sentinel lymphatic mapping for gynecologic malignanciesAnjali Y Hari, Krishnansu S Tewari
Gynecologic Oncology|December 10, 2013
Incorporation of anti-angiogenesis therapy in the management of advanced ovarian carcinoma--mechanistics, review of phase III randomized clinical trials, and regulatory implicationsRamez N Eskander, Krishnansu S Tewari
The Oncologist|March 31, 2016
Clinical Trials of Antiangiogenesis Therapy in Recurrent/Persistent and Metastatic Cervical CancerJill K Alldredge, Krishnansu S Tewari
Pageof 35

Showing results (61-70 of 349) with videos related to

Sort By:
Pageof 35
Recent Patents on Biotechnology|March 11, 2016
Recent Patents for Homologous Recombination Deficiency Assays Among Women with Ovarian CancerChristopher J LaFargue, Krishnansu S Tewari
Gynecologic Oncology|October 15, 2020
The current landscape of molecular profiling in the treatment of epithelial ovarian cancerCarolyn E Haunschild, Krishnansu S Tewari
Expert Review of Anticancer Therapy|October 18, 2016
The safety and efficacy of bevacizumab in the treatment of patients with recurrent or metastatic cervical cancerLindsey E Minion, Krishnansu S Tewari
Clinical Advances in Hematology & Oncology : H&O|February 4, 2022
Current and emerging immunotherapies for recurrent cervical cancerMarisa C Liu, Krishnansu S Tewari
Expert Review of Clinical Pharmacology|July 3, 2014
PARP inhibition and synthetic lethality in ovarian cancerRamez N Eskander, Krishnansu S Tewari
Expert Opinion on Pharmacotherapy|February 4, 2015
Integration of bevacizumab with chemotherapy doublets for advanced cervical cancerLauren S Krill, Krishnansu S Tewari
Clinical Advances in Hematology & Oncology : H&O|February 13, 2015
Development of a platform for systemic antiangiogenesis therapy for advanced cervical cancerKrishnansu S Tewari, Bradley J Monk
Current Opinion in Obstetrics & Gynecology|January 3, 2023
Sentinel lymphatic mapping for gynecologic malignanciesAnjali Y Hari, Krishnansu S Tewari
Gynecologic Oncology|December 10, 2013
Incorporation of anti-angiogenesis therapy in the management of advanced ovarian carcinoma--mechanistics, review of phase III randomized clinical trials, and regulatory implicationsRamez N Eskander, Krishnansu S Tewari
The Oncologist|March 31, 2016
Clinical Trials of Antiangiogenesis Therapy in Recurrent/Persistent and Metastatic Cervical CancerJill K Alldredge, Krishnansu S Tewari
Pageof 35